Novartis appoints new comms head; Jerome Bettis and Sanofi want to know your 'AQ';

> Novartis ($NVS) has appointed Michael Willi as its group head of communications. More

> Four alcoholism meds worked to reduce addiction, a study found, which could dispel skepticism and spur greater use of the drugs. Report

> Amgen ($AMGN) is honoring four cancer survivors as part of its "Breakaway from Cancer" initiative. Release

> Novartis UK has launched a new mobile app that allows multiple sclerosis patients to track their symptoms and relapses. More

> A Johnson & Johnson ($JNJ) advertisement for a yogurt drink has been banned for exaggerating the product's health benefits. More

And Finally... Sanofi ($SNY) has signed on former NFL star Jerome Bettis to help it launch an anaphylaxis quiz during National Asthma and Allergy Awareness Month. Release

Suggested Articles

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

Bluebird said it doesn't expect to complete a U.S. application for the gene therapy until mid-2021 amid COVID-19 and a lack of agreement with the FDA.

W2O Group and California Life Sciences' new data-driven platform tracks top COVID-19 news and conversations in the life science industry.